2018 Pan Pacific Lymphoma Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2018 Pan Pacific Lymphoma Conference

Bench to Bedside
Novel Therapies in Lymphoma
High Grade B-cell Lymphoma
Aggressive T-Cell Lymphoma
Hodgkin Lymphoma
Multiple Myeloma/Plasma Cell Dyscrasia
Common Indolent Lymphoma
Uncommon Indolent Lymphoma
Interprofessional Educational Day

Playback speed

10 seconds

CLL: How to Sequence Therapy Options (Relapse)

By 2018 Pan Pacific Lymphoma Conference FEATURING Susan O'Brien

873 views

August 21, 2018

0 Comments

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Common Indolent Lymphoma

13:32

2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment: A Rational Therapeutic Target in Indolen…

Feat. J. Gribben

10:00

2018 Pan Pacific Lymphoma Conference

The Tumor Microenvironment Using Immune Checkpoint Inhibitors

Feat. J. Gribben

10:54

2018 Pan Pacific Lymphoma Conference

CLL: How to Sequence Therapy Options (Frontline)

Feat. S. O'Brien

12:20

2018 Pan Pacific Lymphoma Conference

CLL: How to Sequence Therapy Options (Relapse)

Feat. S. O'Brien

10:30

2018 Pan Pacific Lymphoma Conference

Evolution of Treatment in Mantle Cell Lymphoma: Clinical Trials vs. …

Feat. A. Goy

15:23

2018 Pan Pacific Lymphoma Conference

Mantle Cell Lymphoma: Strategies to Prevent/Delay Relapse

Feat. A. Goy

06:43

2018 Pan Pacific Lymphoma Conference

Novel Combinations in Follicular Lymphoma in 2018

Feat. J. Friedberg

09:46

2018 Pan Pacific Lymphoma Conference

Mutiple Facets of Marginal Zone Lymphoma: Diagnosis and Classificati…

Feat. E. Zucca